STOCK TITAN

MetLife (NYSE: MET) board discloses 16.1% stake held through policyholder trust

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

MetLife, Inc.’s Board of Directors, acting as an entity, reports beneficial ownership of 102,098,469 shares of MetLife common stock, representing 16.1% of the outstanding class as of July 31, 2026. The shares are held in the MetLife Policyholder Trust for eligible policyholders and permitted transferees.

The Trustee holds legal title and votes the shares largely according to the Board’s recommendations, which causes the Board to be deemed a beneficial owner for voting purposes. Policyholder beneficiaries hold Trust Interests, direct the receipt of dividends and sale proceeds on their allocated shares, and may withdraw shares, including to participate in tender or exchange offers.

Positive

  • None.

Negative

  • None.

Filing Explained

The amendment reports that the Policyholder Trust’s holdings fell to 102,098,469 shares since April 30, 2026, reflecting beneficiary transactions, withdrawals, escheatment, and related trust activity; it changes the reported trust-held voting block rather than documenting a new MetLife issuance.

Beneficially owned shares 102,098,469 shares Shares of MetLife common stock beneficially owned by the Board as an entity as of July 31, 2026
Ownership percentage 16.1% Percent of MetLife’s outstanding common stock represented by 102,098,469 shares
Original shares issued to Trust 494,466,664 shares Shares issued to the MetLife Policyholder Trust on April 7, 2000 under the Plan of Reorganization
Recent decrease in Trust shares 103,885,196 to 102,098,469 shares Change in Trust holdings since April 30, 2026 due to beneficiary-related activity
Shared voting power 102,098,469 shares Shares over which the Board, as an entity, has shared voting power through the Trust arrangement
MetLife Policyholder Trust financial
"The Board is reporting beneficial ownership of 102,098,469 shares held by the MetLife Policyholder Trust"
Trust Interests financial
"Trust Eligible Policyholders have been allocated a number of interests in the Trust ("Trust Interests")"
Plan of Reorganization financial
"under the Plan of Reorganization, dated September 28, 1999, as amended (the "Plan"), of Metropolitan Life Insurance Company"
A plan of reorganization is a formal blueprint used during bankruptcy to rearrange a company’s debts, assets and ownership so it can keep operating. It lays out who gets paid, what creditors and shareholders receive, and how the business will change going forward; think of it as a court-approved debt and recovery roadmap that decides whether investors keep value, receive new securities or cash, or lose their stake.
split-off financial
"pursuant to the Issuer's split-off of Reinsurance Group of America, Incorporated, in September 2008"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many MetLife (MET) shares does the Board report as beneficially owned?

The Board, as an entity, reports beneficial ownership of 102,098,469 shares of MetLife common stock, equal to 16.1% of the outstanding class. These shares are held in the MetLife Policyholder Trust for the benefit of eligible policyholders and permitted transferees.

What is the MetLife Policyholder Trust described in the MET Schedule 13D/A?

The MetLife Policyholder Trust holds MetLife common stock issued under a 1999 Plan of Reorganization. Eligible policyholders received Trust Interests, representing fractional interests in the shares and other trust assets, while a Trustee holds legal title and votes the shares under specified rules.

How has the MetLife Policyholder Trust share balance changed over time for MET?

On April 7, 2000, the Trust received 494,466,664 shares. Through beneficiary transactions, a 2008 split-off, withdrawals and escheatment, the holdings decreased to 102,098,469 shares, as adjusted under the Plan of Reorganization and Trust Agreement provisions.

What recent change in MetLife (MET) Trust holdings is disclosed?

Since April 30, 2026, transactions described in the statement reduced the Trust’s MetLife holdings from 103,885,196 to 102,098,469 shares. These changes reflect beneficiary-related activity rather than open-market trades by the Board itself as an entity.

What voting rights does the MetLife (MET) Board have over Trust shares?

The Board is deemed to beneficially own the shares because it effectively directs how the Trustee votes 102,098,469 shares on most stockholder matters. For defined Beneficiary Consent Matters, the Trustee instead votes in proportion to instructions returned by Trust beneficiaries.

Who receives dividends and sale proceeds from the MetLife (MET) Trust shares?

Trust beneficiaries, not the Board, have the right to receive or direct the receipt of dividends and sale proceeds on shares allocated to them under the Plan of Reorganization and Trust Agreement. They can also instruct withdrawals of shares for resale or corporate transactions.





59156R108

(CUSIP Number)
Monica M. Curtis
MetLife, Inc., 200 Park Avenue
New York, NY, 10166-0188
(212) 578-9500

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
08/06/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Unless otherwise indicated, all information relating to beneficial ownership of Shares by the Reporting Persons is as of July 31, 2026.


SCHEDULE 13D


Board of Directors of MetLife, Inc., as an entity
Signature:*
Name/Title:Daniel S. Glaser
Date:08/06/2026
Signature:*
Name/Title:Carla A. Harris
Date:08/06/2026
Signature:*
Name/Title:Laura J. Hay
Date:08/06/2026
Signature:*
Name/Title:R. Glenn Hubbard
Date:08/06/2026
Signature:*
Name/Title:Jeh C. Johnson
Date:08/06/2026
Signature:*
Name/Title:William E. Kennard
Date:08/06/2026
Signature:*
Name/Title:Michel A. Khalaf
Date:08/06/2026
Signature:*
Name/Title:Diana L. McKenzie
Date:08/06/2026
Signature:*
Name/Title:Christian S. Mumenthaler
Date:08/06/2026
Signature:*
Name/Title:Michelle Seitz
Date:08/06/2026
Signature:*
Name/Title:Mark A. Weinberger
Date:08/06/2026
Comments accompanying signature:
*By /s/ John A. Hall John A. Hall Attorney-in-fact